Ypsomed Holding AG – LSE:0QLQ.L
Ypsomed Holding AG stock price today
Ypsomed Holding AG stock price monthly change
Ypsomed Holding AG stock price quarterly change
Ypsomed Holding AG stock price yearly change
Ypsomed Holding AG key metrics
Market Cap | 4.50B |
Enterprise value | 4.78B |
P/E | 58.81 |
EV/Sales | 8.72 |
EV/EBITDA | 36.04 |
Price/Sales | 8.38 |
Price/Book | 7.46 |
PEG ratio | 1.02 |
EPS | 9.54 |
Revenue | 1.04B |
EBITDA | 271.78M |
Income | 129.64M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 14.29% |
Oper. margin | 15.13% |
Gross margin | 34.47% |
EBIT margin | 15.13% |
EBITDA margin | 25.99% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeYpsomed Holding AG stock price history
Ypsomed Holding AG stock forecast
Ypsomed Holding AG financial statements
| Sep 2022 | 244.24M | 15.43M | 6.32% |
|---|---|---|---|
| Mar 2023 | 253.21M | 35.83M | 14.15% |
| Sep 2023 | 255.39M | 36.57M | 14.32% |
| Mar 2024 | 293.06M | 41.78M | 14.26% |
| 2028 | 968M | 0 |
|---|
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 22.64% |
|---|
| 2016 | 0.44% |
|---|---|
| 2017 | 0.53% |
| 2019 | 1.09% |
| 2020 | 0.44% |
| 2022 | 0.71% |
| Sep 2022 | 790843000 | 281.80M | 35.63% |
|---|---|---|---|
| Dec 2022 | 861879000 | 299.54M | 34.75% |
| Sep 2023 | 936683000 | 355.49M | 37.95% |
| Mar 2024 | 1101395000 | 475.93M | 43.21% |
| Sep 2022 | 69.74M | -83.16M | 13.96M |
|---|---|---|---|
| Mar 2023 | 59.78M | -38.85M | -12.69M |
| Sep 2023 | 73.43M | -89.91M | 28.25M |
| Mar 2024 | 89.79M | -105.15M | 52.81M |
Ypsomed Holding AG alternative data
| Aug 2023 | 2,059 |
|---|---|
| Sep 2023 | 2,059 |
| Oct 2023 | 2,059 |
| Nov 2023 | 2,059 |
| Dec 2023 | 2,200 |
| Jan 2024 | 2,200 |
| Feb 2024 | 2,200 |
| Mar 2024 | 2,200 |
| Apr 2024 | 2,200 |
| May 2024 | 2,200 |
| Jun 2024 | 2,296 |
| Jul 2024 | 2,296 |
Ypsomed Holding AG other data
| Insider | Compensation |
|---|---|
Mr. Simon Michel (1977) Chief Executive Officer | $668,100 |
Mr. Niklaus Ramseier Chief Financial Officer | |
Mr. Frank Mengis Chief Operating Officer & Senior Vice President of Operations | |
Mr. Hans-Ulrich Lehmann Senior Vice President of Technology & Chief Technology Officer | |
Thomas Kutt Head of Investor Relations | |
Dr. Beat Maurer Senior Vice President of Legal Services & Intellectual Property and Sec. of the Board | |
Mr. Michael Zaugg Senior Vice President of HR | |
Dr. Eberhard Bauer Senior Vice President of Diabetes Care | |
Ms. Ulrike Bauer Senior Vice President of Delivery Systems |
-
What's the price of Ypsomed Holding AG stock today?
One share of Ypsomed Holding AG stock can currently be purchased for approximately $191.24.
-
When is Ypsomed Holding AG's next earnings date?
Unfortunately, Ypsomed Holding AG's (0QLQ.L) next earnings date is currently unknown.
-
Does Ypsomed Holding AG pay dividends?
Yes, Ypsomed Holding AG pays dividends and its trailing 12-month yield is 0.59% with 23% payout ratio. The last Ypsomed Holding AG stock dividend of $0.1 was paid on 10 Jul 2020.
-
How much money does Ypsomed Holding AG make?
Ypsomed Holding AG has a market capitalization of 4.50B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17.99% to 548.46M US dollars.
-
What is Ypsomed Holding AG's stock symbol?
Ypsomed Holding AG is traded on the LSE under the ticker symbol "0QLQ.L".
-
What is Ypsomed Holding AG's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of Ypsomed Holding AG?
Shares of Ypsomed Holding AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Ypsomed Holding AG's key executives?
Ypsomed Holding AG's management team includes the following people:
- Mr. Simon Michel Chief Executive Officer(age: 48, pay: $668,100)
- Mr. Niklaus Ramseier Chief Financial Officer
- Mr. Frank Mengis Chief Operating Officer & Senior Vice President of Operations
- Mr. Hans-Ulrich Lehmann Senior Vice President of Technology & Chief Technology Officer
- Thomas Kutt Head of Investor Relations
- Dr. Beat Maurer Senior Vice President of Legal Services & Intellectual Property and Sec. of the Board
- Mr. Michael Zaugg Senior Vice President of HR
- Dr. Eberhard Bauer Senior Vice President of Diabetes Care
- Ms. Ulrike Bauer Senior Vice President of Delivery Systems
-
How many employees does Ypsomed Holding AG have?
As Jul 2024, Ypsomed Holding AG employs 2,296 workers, which is 4% more then previous quarter.
-
When Ypsomed Holding AG went public?
Ypsomed Holding AG is publicly traded company for more then 9 years since IPO on 19 May 2016.
-
What is Ypsomed Holding AG's official website?
The official website for Ypsomed Holding AG is ypsomed.com.
-
How can i contact Ypsomed Holding AG?
Ypsomed Holding AG can be reached via phone at +41 34 424 41 11.
Ypsomed Holding AG company profile:
Ypsomed Holding AG
ypsomed.comLSE
2,296
Medical - Equipment & Services
Healthcare
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Burgdorf, 3401
:
ISIN: CH0019396990
:
